Acronym | IMMUcan |
---|
Status | Finished |
---|
Effective start/end date | 1/03/2019 → 31/08/2024 |
---|
- King's College London
- EORTC European Organisation for Research and Treatment of Cancer (lead)
- SIB Swiss Institute of Bioinformatics
- University Institute for Social and Preventive Medicine
- Luxembourg Institute of Health
- KU Leuven
- Institut Jules Bordet
- University of Birmingham
- MARIE CURIE RESEARCH INSTITUTE
- University of Zürich
- Charité University of Medicine Berlin
- Ctr Genom Regulat CRG UPF, Genes & Dis Program
- Weizmann Institute of Science
- INSERM
- Merck KGaA
- AbbVie Inc.
- Bayer AG
- Eli Lilly & Co Ltd
- GSK GlaxoSmithKline Research & Development Ltd
- Janssen Research
- Sanofi S.A.
- Servier
- Pierre Fabre
- EC European Commission: £14,977,200.00